Werewolf Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(14.2%),Peter Kolchinsky(14.2%)等
04:59
Werewolf Therapeutics | 10-Q:季度报表
05/03 19:15
Werewolf Therapeutics | 8-K:Werewolf Therapeutics公布2024年第一季度财务业绩并提供业务最新情况
05/03 19:10
Werewolf Therapeutics | ARS:年度报告
04/12 19:21
Werewolf Therapeutics | DEFA14A:其他
04/12 19:21
Werewolf Therapeutics | DEF 14A:股东委托书决议
04/12 19:21
Werewolf Therapeutics | S-8:员工福利计划证券登记
03/07 20:24
Werewolf Therapeutics | 10-K:年度报表
03/07 20:19
Werewolf Therapeutics | 8-K:Werewolf Therapeutics公布2023年第四季度和全年财务业绩并提供业务最新情况
03/07 20:14
Werewolf Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(15.2%),Peter Kolchinsky(15.2%)等
02/15 06:23
Werewolf Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-PFM Health Sciences, LP(9.6%),PFM Health Sciences GP, LLC(9.6%)等
02/15 05:14
Werewolf Therapeutics | SC 13G:超过5%持股股东披露文件-BANK OF AMERICA CORPORATION(5.8%)
02/14 08:01
Werewolf Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Rubric Capital Management LP(5.35%),David Rosen(5.35%)
02/12 20:09
Werewolf Therapeutics | 8-K:重大事件
02/10 05:41
Werewolf Therapeutics | 424B5:募资说明书
02/10 05:40
Werewolf Therapeutics | 8-K:重大事件
01/08 13:00
Werewolf Therapeutics | 4:持股变动声明-董事 Atkins Michael B.
01/04 13:00
Werewolf Therapeutics | 3:首次持股声明-董事 Atkins Michael B.
01/04 13:00
Werewolf Therapeutics | 8-K:重大事件
01/04 13:00
Werewolf Therapeutics | 4:持股变动声明-高管 Trost Timothy W.
01/04 13:00
暂无数据
暂无数据